Penumbra, Inc. (PEN:NYSE) closed at $321.50 on October 15, 2026, up 0.43% on the day. The stock trades 11.3% below its 52-week high of $362.41 and 45.3% above its 52-week low of $221.26. Over the past year, it gained 26.7%. Penumbra, Inc. is part of the Health Care sector (Medical/Dental Instruments).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.26% | +0.53% | +0.57% | -2.91% | +26.73% |
In 252 trading sessions since October 14, 2025, PEN closed higher on 128 days (51%). Its best day was November 6, 2025 (+17.32%) and its worst was January 13, 2026 (-5.79%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.
Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.
Find more stocks like PEN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.